Table 3 Examples of clinical mixed strain infections with disentangled the drug resistance mutations established for each strain using our GMM.

From: Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis

ID

Drug resistance (DR) profile

Strains

Major; minor

Major prop.*

Minor prop.*

Major strain

DR mutations

Minor strain

DR mutations

ERR4796347 (India)

Fluoroquinolones, ethionamide, ethambutol, streptomycin, rifampicin, isoniazid, pyrazinamide

L4.3.3; L2.2.1;

(0.64) [0.61]

(0.36) [0.39]

Ala90Val-gyrA

Ser450Leu-rpoB

n.514A>C-rrs

c.-15C>T-fabG1

Ser315Thr-katG

Thr160Ala-pncA

Thr100Ile-pncA

Met306Ile-embB

 

ERR4829977 (Pakistan)

Bedaquiline, clofazimine, ethionamide, ethambutol, isoniazid, rifampicin, streptomycin,

L3; L2.2.1.1

(0.88) [0.79]

(0.12) [0.21]

p.Ile67fs-mmpR5

p.His445Asn-rpoB

p.Lys88Arg-rpsL

c.-15C>T-fabG1

p.Gly406Asp-embB

ERR4797884 (India)

Aminoglycosides, capreomycin, ethambutol, ethionamide, fluoroquinolones, isoniazid, kanamycin, linezolid, moxifloxacin, PAS, pyrazinamide, rifampicin, streptomycin

L3.1.2.1; L2.2.1

(0.61) [0.55]

(0.39) [0.45]

Ser315Thr katG

Glu170* gid

Asp94Gly gyrA

Ser450Leu rpoB

Lys43Arg rpsL

Cys154Arg rplC

n.1484G>T rrs

c.-8T>C fabG1

Ser315Thr katG

Thr177Pro pncA

c.-16C>T thyX

Met306Val embB

  1. *Mixing proportions: (TB-Profiler prediction) [GMM prediction]; PAS P-aminosalicyclic acid.